Ignite II

gmkb

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

- GUARDD-US APOL1 Genetic Testing Manuscript Published March 6, 2026
  A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
- ADOPT-PGx Acute Pain Manuscript Published with Invited Commentary February 20, 2026
  The ADOPT-PGx study examined the impact of genotype-guided opioid prescribing on postoperative pain management. Results from the study were recently published in JAMA Network Open, accompanied by an invited commentary reflecting on the findings and their implications for pharmacogenetics in ...

Search for:

GMKBignite toolbox Implementation Guides

Genetic Testing for APOL1 in Adults With Hypertension – The GUARDD-US Randomized Clinical Trial

Posted on March 6, 2026 by K F

Michael T. Eadon, MD; Kerri L. Cavanaugh, MD, MHS; Lilin She, PhD

DOI: 10.1001/jamanetworkopen.2026.0528
Article on Jama Network

This entry was posted in GUARDD-US, IGNITE Network, News, Publication. Bookmark the permalink.

← ADOPT-PGx Acute Pain Manuscript Published with Invited Commentary

GUARDD-US APOL1 Genetic Testing Manuscript Published →

You must be logged in to post a comment.

Home
IGNITE
- ADOPT PGx
- GUARDD-US
IGNITE GDP
Publications
Affiliates
Training Opportunities
News & Events
- News
- Event Calendar

IGNITE is an NIH-funded network dedicated to supporting the implementation of genomics in healthcare. Contact us to learn more about IGNITE and the work currently being conducted by the network

Contact IGNITE

Privacy Statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.

Leave a Reply